← Back to all substances
M

tramadol

243ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

1 INDICATIONS AND USAGE Tramadol hydrochloride extended-release tablets are indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids. Limitations of Use • Because o...

Known as: TRAMADOL HYDROCHLORIDE
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
211,141
Total in FDA
82%
Serious Reports
91
Fatal Outcomes

Seriousness

Serious
408
Non-Serious
92

Sex Distribution

Male
190
Female
295
Unknown
15

Age Distribution

0-17
2
18-40
80
41-64
207
65-84
124
85+
18
Unknown
69

Outcomes

Recovered/Resolved
351
Recovering/Resolving
141
Not Recovered/Not Resolved
298
Recovered with Sequelae
54
Fatal
91
Unknown
1002

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-aa6488
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...